Member Info for Retireby40

Come in because MWG was managed very poorly shouldn’t detract from its amazing tech which is protected snd award winning. GB has his critics and quite right but he does have vision and i believe both Rinocloud and MWG superb acquisitions. Rinocloud quickly generated cash and with it adding value to MWG and labskin I’m sure the group will start to generate cash too (profitability). I think MWG a steal at the price and I think it’ll demonstrate that by YE.

£3.6m in orders, 80% from China and a lot more to come from there snd ROW. I do think the collaborative approach spot on and think we’ll see a sustainable business model n the not too distant. We need to spend to accelerate growth but short term I wanna see PD timeline and labskin order book.

One more time at £21m MWG acquisition great business IMO!

I doubt any LTHs are selling due to GB and his twitter ramping, I think most get it now. I think some are selling as are not too impressed with recent RNSs and for me they we’re okay but not worth suggesting on social media anything else. I do think that potential investors rather than current ones are more of a concern and I suspect some will be put off by GB and his twitter antics.

AVCT had a similar market cap to us and now it’s crazy and some £500m and attracted some very impressive investors at 120p. The CEO is impressive snd if going from £50m to £500m market cap he doesn’t look out of place. If we exploded to say £250m market cap or £150m say is GB the man to take us to the next level, would he seem out of place? That remains to be seen, I’m not sure but I do think his social media more like an MD of a family business rather than a CEO or Chairman of PLCs.

Anyway, he keeps building up on social media and delivering mediocre RNSs. Let’s see if he can finally deliver the all important PD one and let us know (as they did last year) what the order book is.

Ha, it’s more likely Avacta which has had its BAMS test under validation for months! CONDOR seems slow and not fit for purpose. Bruker published a research paper on its work with AVCT and it looks as good as PCR.

BT on the back burner until H2, let’s have some genuinely positive news on PD and not fluff and jam tomorrow.I’d be amazing if BT is commercialised this year but you never know but PD I’m expecting to be ready Q2 maybe. Hope so!

Yeah I’m gonna pipe down! It’s bloody frustrating though and the market clearly doesn’t believe. That means there should be a lot of upside when potential turns in to reality.

Hopefully we get news on labskin as well as PD.

To be fair I’m still peeved I didn’t reduce a little while ago and we’re 20% down and the co I was buying have doubled. The fundamentals here are laid and are solid but I was expecting more from the last 2 RNSs which have been poorly written IMO. More to come this month I’m sure but we need solid news.

I love the skintrustclub website BTW. I hope labskin is continuing to grow and now generate cash as it’s our core competence still. We know MWG going great so let’s hear from labskin!

Chesh I’m a little frustrated with their crap RNSs and the fact they need to follow up with explanation says it all. Typos and wrong website addresses are one thing but having to explain their poor releases another.

I want to hear that labskin (our bread and butter) is still going great guns. They were happy to tell us on 30 March last year we had £2m in orders so I think a good starting point to improve sentiment here would be to let us know (assuming it’s good!) this year we have, for instance, £4m labskin orders as well as £3.6m in MWG so we’re not far off forecast. These RNSs are positive but like me the market wants to know where we are now and of course whether PD will be ready for launch Q2 and if not some clear timeline.

I really hope the next RNSs are less ambiguous. The last 2 have posed more questions. The market isn’t impressed with all the rhetoric although I like what we’re doing with MSYS for DVRG holders we want some tangible news and not jam tomorrow. 30th March last year we RNS’d we had £2m labskin orders (half of which was invoiced H2) which is great so can we expect similar detail this year? We know we’re getting an update on 31st so they will hopefully provide this as well as what we’re planning to do. As well as looking forward we wanna know where we are now. They were happy to do so last year so hopefully this year with £3.6m MWG orders and hopefully we’ve doubled labskin so orders so £4m and a total of £7.6m in orders would improve sentiment and the share price.

Let’s have what’s going on now with orders, when PD is likely to be ready for sale and retrofit as well as BT realistic timescale (end of year maybe?). We need substance rather than woolly RNSs that then need explaining.

I was expecting a few decent RNSs this month to get us back into the 40s and beyond and after 2 we’re below what Mrs B sold at. No surprise there given the content of the last 2 RNSs. All okay but jam tomorrow so I really hope the third RNS has genuine substance. We need clear info on when PD will come to market, how quickly we can ramp up production, do we have the cash to do so (some orders will be 50% up front which could help massively) and what is the current order book? Last year was £2m end of March and this year should surely be £7m or so? The recent RNSs are positive but the market wants to see some orders now (like last year) and wants to see what’s going to generate money in the short term (Q2-3). Hopefully we get this info and not jam tomo waffle.

So we’re developing a new breathalyser? These RNSs are so poorly written. No wonder the market is not bothered. See below.

Using DeepVerge’s newly-developed AI data analytics, the plan is to create a breathalyser that can immediately and accurately detect the SARS-CoV-2 virus, providing a point of care diagnostic.

I hope before month’s end we get a meaningful RNS on PD and some realistic timelines. Also, last March we were told we had £2m in orders so with £3.6m MWG we’re surely looking at £7m or so in orders?!

NU you’ve got a point re the current share price range and the fact rises aren’t sustained. That said we have 2 multimillion £ pitches we’re waiting on so if one of those drops we will move out of the current range.

Also, if we do launch PD which will be unique and put us on many a radar snd generate additional revenue from existing and new clients I imagine we’ll go 100p+.

We should have a detailed update on labskin as well as PD testing so hopefully that will move us out of the current range and we can go into Q2 with renewed confidence and attract new money.

T.Rat, I agree with you the hard part has been done in terms of development (and most costs incurred) and we’re in good shape. I was merely pointing out we’d be doing well to get this launched this year. Just being a realist!

I expect PD to be launched soon and GB hopes as per twitter by spring/early summer too. Exciting times.

From the saint on advfn -

Listened to Justin Waite's podcast last night with Alan Green, thought a few notes to counter Justin's comments regarding revenues for those that are new looking in as Alan didn't explain the proposition well enough IMO.

End of year 2020 revenues estimated at £2.2 million, however it should be noted these revenues are net, gross collected via content owner, say Tencent. Tencent collect 100% being ~£7.4 million paying an estimated 30% of that to Mirriad £2.2m, that aside the forecast does not account for company progress latter part of 2020, these will impact revenues for 2021 -

- Tier 1 partner signed 28th Oct 2020, most likely Disney subject to NDA.

- Music Alliance launched Nov 2020, likely no revenues for 2020

- Launch of Live TV/Sports advertising 2021 (think live eSports/football/Cricket etc)

- Programmatic advertising 2021

- More Tier 1 partners under NDA

- ~£35 million cash end of 2020

To reiterate point on revenues, Mirriad's solution has generated estimated gross revenues in excess of £7 million, on a conservative basis, the revenue received by Mirriad is their share, there's no other third party to be paid.

Forward looking from 2020 into 2021 we have a Tier 1 partner who have trialed Mirriad's magic in 4 shows during December with further shows now being cleared, it was mentioned during a recent podcast that potential early revenues from this partner could be in the region of $17 million.

Music Alliance launch is slightly different in that gross revenues are collected by Mirriad with Music Labels/Artist paid by Mirriad. Music videos have astonishing view rates online likes of Ed Sheeran's Shape of You taking just 97.4 days to achieve 1 billion YouTube views or Maroon 5' Girls Like You, 129 days. Advertisers can now connect with artists monetising past and future content in a non intrusive way, with the impacts of covid on music venues this new opportunity will provide a welcome income for many.

Launch of Live TV/Sports later this year will be an absolute game-changer for advertisers and the sports industry as a whole, being able to change advertising viewed in each country or region during live broadcast will boost appeal to advertisers, Cricket, football, Formula 1, Boxing, Tennis advertising specific to country or region by way of example.

There's much more to Mirriad's magic, above is a brief example as to how and why this has potential to be a global game-changer in how brands and viewers come together in a modern era, huge strides have been made this last year that should materially improve the pace in which Mirriad evolves over coming months and years.

@Huancheng Wang, an application engineer of Modern Water’s Shanghai office, presented an overview of Modern Water’s innovative water quality monitoring solutions in a webinar hosted by instrument.com.cn on March 17, 2021. The webinar focused on the company’s products for environmental early warning and emergency response, Modern Water’s innovative Microtox PD Covid-19 wastewater detection system, and. the company’s new Ecological Water Operating System (“ecowaterOS”). #Deepverge #ModernWater #Microtox #EcowaterOS #monitoring #MicrotoxPD #water #innovation

Yeah nice spot and the website is fantastic. Really clean, great iconography, palette and I’m sure the app will be as good. Still wondering why they spent the money advertising in The Sun! Clearly they’ll take advice from the media planner/buyer but I’m surprised the readers are largely the target market. Anyway, they’ll see how many registrations came as a result and hopefully it was an effective ad.

All being well this could be a stand alone target for a large player. In the short term let’s hope we have solid RNSs that can sustain any share price rise as the recent ones haven’t been able to. Am not surprised the latest one didn’t hold gains.

A fair bit of red today. To be fair the fundamentals here are as good as they have ever been. I just think trust and credibility needs to be rebuilt. Hopefully the next couple of RNSs do just that. I would have sold on 17th in the late 30s but I believed and still do that we’ll have a really positive RNS on you guessed it PD so didn’t sell any. That RNS better be good as it’ll be frustrating as feck!

Ha, got the cricket on in the background and just about to put some lovely coffee on and will have porridge, granola and fruit (banana and blueberries). Breakfast of champions.

DVRG reminds me on my beloved Spurs, we struggle to hold onto a lead!

Real-time wastewater will be gold standard and surely we can dominate the space? The current 5 provinces we work with will want retrofitted units snd the 18 other provinces will also want them. Then there’s the US, EU and RoW. We can truly dominate snd have amazing reagent and AI recurring revs. Could be transformational.

Forgot you can’t edit on here, ball ache. I seemed too negative there but what I need to say is I hope we get some meaningful RNSs going into H2. I think we all expect an RNS this month which will cover skintrustclub launch as well as an update on labskin (hopefully making waves in China as its new regs come into play) and of course a detailed update on PD. To be fair a really exciting end to the month and I’m especially excited about PD as I’ve said since the get-go.

Last March we had an RNS that included £2m in orders and given we did £2.4m Q4 and have £3.6m in MWG orders surely we can see at least £6m in sales/orders come end of March and hopefully more as we have visibility going into the next Q so could even be £8.4m if we can confirmed labskin recurring revs.

Anyway, onwards and upwards!

T.Rat, be realistic re BT. There is no way it’ll be ready for July as you hope. Since field testing started in November so 4 months we’ve managed 40 tests snd we need 400. It then needs a CE mark. Fab pumping it as he did before the AGM and at it didn’t help re expectations and nor did the Nov RNS stating we’d have enough data in early 2021 when we have 10% of it coming out of Q1. As a couple of articles GB has retweeted and liked on twitter it says this could be ready this year which tells me if it is (which would be a super achievement) it will be Q4 and I imagine towards the back end.

I expect PD to be different and I hope we are given a realistic and clear timeline when this is likely. I hope we don’t get another woolly jam tomorrow RNS like we did re BT. I never expected BT to be ready but GB’s enthusiasm gets him carried away which isn’t helpful as many expected it ready Q1 or early Q2.

Anyway, I really hope the next update is meaningful.

I am lucky enough to be some 50% up (mostly through my early MWG buys) so can’t complain but in the 2 years I’ve been invested I’ve seen all of my other investments multibag so human nature dictates I wish this was my smallest not largest holding (Although AVCT nearly ahead given recent rises).

I like GB’s vision and enthusiasm and hope he is the CEO to take this to the next level and attract the kind of shareholders/investors we need. Time will tell. There’s no doubt the businesses have been turned around really well But moving to the next level requires a different skill set. That said the performance will do the talking snd money will follow. Will see what Q2 brings.

Agreed NU. For me it’s all about China initially which is the largest market and where our tech is very much appreciated. We also have feet on the ground and lots of distributors.